Navigation Links
J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases
Date:5/29/2009

ROCKVILLE, Md., May 29 /PRNewswire-USNewswire/ -- The J. Craig Venter Institute (JCVI) announced today that they have been awarded a $43 million, five year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as one of their Genomic Sequencing Centers for Infectious Diseases (GSCID). Led by co-principal investigators, William Nierman, Ph.D., and Robert Strausberg, Ph.D., the contract will enable JCVI to continue to expand its decades-long expertise in infectious diseases and human genomics by providing important genomic services to the broader scientific community.

"The current worldwide outbreak of H1N1 flu, and the increasing prevalence of new and emerging infectious diseases makes our work more necessary than ever," said J. Craig Venter, Ph.D., founder and president, JCVI. "Since our first sequencing of the Haemophilus influenzae genome in 1995, to our most recent work in sequencing the isolates from the 2009 H1N1 flu outbreak, JCVI is committed to being a major source for leading edge genomic data and tools to further scientific understanding of the microbial world and how it affects humans."

Over the course of the five year contract JCVI will work collaboratively with NIAID to provide genomics resources that are responsive to the needs of the global infectious disease community. To do this, JCVI investigators with scientific and technical expertise in infectious diseases, human genomics, DNA sequencing, genotyping, and bioinformatics, will continue to generate comprehensive genomic data sets that will enable pathogen countermeasures such as vaccines, therapeutics, diagnostics, and surveillance methods.

Since 2003, JCVI (and through legacy organization, TIGR) has been providing these important services as a contractor under what was previously referred to as the NIAID Microbial Genome Centers program. During that contract period JCVI sequenced and analyzed 185 eukaryotic and prokaryotic genomes, and more than 3000 viral genomes. JCVI's participation in the NIH Human Microbiome program was also initiated under this contract program.

The recent work conducted at JCVI and led by David Spiro, Ph.D. in sequencing and analyzing the H1N1 (swine origin) influenza isolates, is supported by NIAID as part of the GSCID contract. Dr. Spiro and the team at JCVI continue to work closely with NIAID, National Center for Biotechnology Information (NCBI), and the global scientific community to monitor and better understand the evolution of the current virus with the goal of anticipating and developing new and better therapeutics, diagnostics and vaccines to this constantly mutating viral threat.

About the J. Craig Venter Institute

The JCVI is a not-for-profit research institute in Rockville, MD and San Diego, CA dedicated to the advancement of the science of genomics; the understanding of its implications for society; and communication of those results to the scientific community, the public, and policymakers. Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 400 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics/informatics, information technology, high-throughput DNA sequencing, genomic and environmental policy research, and public education in science and science policy. The legacy organizations of the JCVI are: The Institute for Genomic Research (TIGR), The Center for the Advancement of Genomics (TCAG), the Institute for Biological Energy Alternatives (IBEA), the Joint Technology Center (JTC), and the J. Craig Venter Science Foundation. The JCVI is a 501 (c) (3) organization. For additional information, please visit http://www.JCVI.org.

Media Contact: Heather Kowalski, hkowalski@jcvi.org, 301-943-8879


'/>"/>
SOURCE J. Craig Venter Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AMTA Applauds Craigslist Decision, Calls for Protection of Massage Therapists
2. Martha Byrne (ex-Lily ATWT) and Scott Bryce (ex-Craig ATWT) to be Interviewed Live
3. V. Craig Jordan, Internationally Renowned Breast Cancer Scientist, Joins Georgetowns Lombardi Comprehensive Cancer Center
4. Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest
5. Jenny Craig Announces Nationwide Voluntary Recall of Jennys Cuisine(R) Anytime Peanut Butter Flavor Nutritional Bars Due to Possible Peanut Corporation of America (PCA) Contamination and Potential Health Risk
6. Phylicia Rashad Selected as New Spokesperson for Jenny Craig
7. Jenny Craig Inc. Announces New Wellness Campaign: The Great Take-Off
8. Queen Latifah to Continue Her Role as Jenny Craig Ambassador
9. Craig A. Norris Appointed to Providence Service Corporation Board of Directors
10. Jenny Craig Announces Finalists for the 2008 Ideal Size Contest
11. Craig W. Philips Takes Helm at CTI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
Breaking Medicine Technology: